Eli Lilly expects Medicare about-face on Alzheimer’s drugs coverage
By
Alicia Lasek
Apr 23, 2023
New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.
Medicare Advantage enrollees get less post-acute care than traditional beneficiaries: analysis
By
Joe Bush
Sep 19, 2022
Members of Medicare Advantage plans used post-acute care less than people with traditional Medicare, according to an analysis of 62 studies.
Federal court opens door for nursing homes to challenge Medicare, Medicaid rules
By
Danielle Brown
Apr 30, 2021
Providers may challenge rules and regulations established by federal agencies that they believe violate the Medicare and Medicaid Acts, thanks to a ruling this week by a federal court.
Providers grateful for certain opportunities in proposed 2025 Medicare pay rule
By
James M. Berklan
Apr 02, 2024
Even though debate will continue about how much Medicare reimbursement should rise next year, there’s little disagreement that the Centers for Medicare & Medicaid Services got at least a few things right...